| 000 | 01878 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513221603.0 | ||
| 264 | 0 | _c20010222 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/01.cir.102.13.1490 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeter, K | |
| 245 | 0 | 0 |
_aFlow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine. _h[electronic resource] |
| 260 |
_bCirculation _cSep 2000 |
||
| 300 |
_a1490-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xblood |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xblood |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xblood |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xblood |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Proteins _xblood |
| 650 | 0 | 4 |
_aTiclopidine _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xblood |
| 700 | 1 | _aKohler, B | |
| 700 | 1 | _aStraub, A | |
| 700 | 1 | _aRuef, J | |
| 700 | 1 | _aMoser, M | |
| 700 | 1 | _aNordt, T | |
| 700 | 1 | _aOlschewski, M | |
| 700 | 1 | _aOhman, M E | |
| 700 | 1 | _aKübler, W | |
| 700 | 1 | _aBode, C | |
| 773 | 0 |
_tCirculation _gvol. 102 _gno. 13 _gp. 1490-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.102.13.1490 _zAvailable from publisher's website |
| 999 |
_c10950090 _d10950090 |
||